Welcome to LookChem.com Sign In|Join Free

CAS

  • or

66947-92-0

Post Buying Request

66947-92-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

66947-92-0 Usage

Description

2-AMINO-BENZOTHIAZOLE-6-CARBOXYLIC ACID METHYL ESTER, also known as Methyl 2-amino-1,3-benzothiazole-6-carboxylate, is an organic compound that serves as a key reactant in the synthesis of various chemical products. It is characterized by its unique molecular structure, which includes a benzothiazole ring, an amino group, and a carboxylic acid ester group. This versatile chemical intermediate is known for its potential applications in the development of dyes and other specialty chemicals.

Uses

Used in Dye Industry:
2-AMINO-BENZOTHIAZOLE-6-CARBOXYLIC ACID METHYL ESTER is used as a reactant in the preparation of azo-metal chelate dyes. It plays a crucial role in the synthesis of these dyes, which are known for their colorfastness, brightness, and resistance to fading. These dyes are widely used in various applications, including textiles, plastics, and printing inks, due to their superior properties and performance.

Check Digit Verification of cas no

The CAS Registry Mumber 66947-92-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,9,4 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 66947-92:
(7*6)+(6*6)+(5*9)+(4*4)+(3*7)+(2*9)+(1*2)=180
180 % 10 = 0
So 66947-92-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O2S/c1-13-8(12)5-2-3-6-7(4-5)14-9(10)11-6/h2-4H,1H3,(H2,10,11)

66947-92-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2-amino-1,3-benzothiazole-6-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 2-amino-1,3-benzothiazole-6-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66947-92-0 SDS

66947-92-0Relevant articles and documents

Iodine-catalyzed amination of benzothiazoles with KSeCN in water to access primary 2-aminobenzothiazoles

Zhu, Yu-Shen,Shi, Linlin,Fu, Lianrong,Chen, Xiran,Zhu, Xinju,Hao, Xin-Qi,Song, Mao-Ping

supporting information, p. 1497 - 1500 (2021/09/09)

A facile and sustainable approach for the amination of benzothiazoles with KSeCN using iodine as the catalyst in water has been disclosed under transition-metal free conditions. The reaction proceeded smoothly to afford various primary 2-amino benzothiazoles in up to 96% yield. A series of control experiments were performed, suggesting a ring-opening mechanism was involved via a radical process. This protocol provides efficient synthesis of primary 2-aminobenzothiazoles

Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis

Li, Junyou,Liu, Mengqi,Li, Yazhou,Sun, Dan-Dan,Shu, Zhihao,Tan, Qian,Guo, Shimeng,Xie, Rongrong,Gao, Lixin,Ru, Hongbo,Zang, Yi,Liu, Hong,Li, Jia,Zhou, Yu

, p. 12748 - 12772 (2020/12/17)

Farnesoid X receptor (FXR) plays a key role in bile acid homeostasis, inflammation, fibrosis, and metabolism of lipid and glucose and becomes a promising therapeutic target for nonalcoholic steatohepatitis (NASH) or other FXR-dependent diseases. The phase III trial results of obeticholic acid demonstrate that the FXR agonists emerge as a promising intervention in patients with NASH and fibrosis, but this bile acid-derived FXR agonist brings severe pruritus and an elevated risk of cardiovascular disease for patients. Herein, we reported our efforts in the discovery of a series of non-bile acid FXR agonists, and 36 compounds were designed and synthesized based on the structure-based drug design and structural optimization strategies. Particularly, compound 42 is a highly potent and selective FXR agonist, along with good pharmacokinetic profiles, high liver distribution, and preferable in vivo efficacy, indicating that it is a potential candidate for the treatment of NASH or other FXR-dependent diseases.

FXR regulator with spirane structure

-

Paragraph 0092; 0094; 0095; 0096; 0097, (2019/01/14)

The invention provides a new compound which has certain agonist activity on a Farnesoid X receptor (FXR) and is used for treating FXR mediated diseases and/or symptoms such as liver disease and gastrointestinal disease. (The formula is shown in the description.).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 66947-92-0